Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.
about
Therapeutic interventions for daytime somnolence in Parkinson's diseasePatient-reported outcomes as a source of evidence in off-label prescribing: analysis of data from PatientsLikeMeTreatment of narcolepsy and other hypersomnias of central originThe recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's diseaseEfficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysisThe Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's diseaseAtomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseDaytime sleepiness in elderly Parkinson's disease patients and treatment with the psychostimulant modafinil: A preliminary study.Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study.Parkinson's disease: the quintessential neuropsychiatric disorderA review of the use of modafinil for attention-deficit hyperactivity disorder.Modafinil: Parkinson disease-related somnolencePramipexole for the treatment of early Parkinson's disease.Monoamine reuptake inhibitors in Parkinson's disease.Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.Tick-borne bacterial, rickettsial, spirochetal, and protozoal infectious diseases in the United States: a comprehensive review.Caffeine for treatment of Parkinson disease: a randomized controlled trial.Recognition and diagnosis of sleep disorders in Parkinson's disease.Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.Dopamine agonists in the treatment of Parkinson's disease.Evaluation and management of the non-motor features of Parkinson's disease.Sleep-related problems of Parkinson's disease.Emerging drugs for Parkinson's disease.Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.Sleep disturbances in Parkinson's disease patients and management options.The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms.Update on the use of pramipexole in the treatment of Parkinson's disease.Management of the behavioral aspects of Parkinson's disease.Circadian and sleep disorders in Parkinson's disease.Role of dopamine agonists in Parkinson's disease: an update.Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue.Evidence-based recommendations for the assessment and management of sleep disorders in older personsNeuropsychiatric symptoms in Parkinson's disease.Agitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use.Nonmotor disturbances in Parkinson's disease.Nonmotor symptoms in Parkinson's disease.Drug therapy in patients with Parkinson's disease.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.Current status of safinamide for the drug portfolio of Parkinson's disease therapy.
P2860
Q24243418-02D70004-1B7F-478F-8E9E-299E7436A08AQ24595345-0B452750-0612-4168-B6DF-24D189E9B81BQ24648883-5250D44A-8318-4FAD-944F-8E35441C83FDQ26745661-344008D2-945F-4B0E-8883-AC9C39E76682Q28535752-33F789E9-136B-4E94-88D5-B154447E7602Q33607256-E8EA24B9-EEE9-4003-AC2E-4A6FFEC3FAA8Q33647691-6F336AFF-FAE3-4923-B5C5-DDD9D9E595DEQ33787218-3CD84DBD-6FC0-4B89-B4BA-233C6AB03BD0Q33884712-E59DBF07-A878-4F62-BF0E-36445BFD5BF7Q33917094-46E2A549-F2C6-4E14-9185-46D027232056Q33995154-3C699027-67D3-49D4-BCE0-026FBCD5CE62Q34612982-D5492E81-A9A1-429A-A8DA-4E90AD6D507BQ34630735-3E107D08-0223-4DFF-9E5E-981D2FA01B5EQ35165280-933E9963-47B7-4C56-9A86-9230E7CBA5C1Q35211225-37E245F0-9988-43A8-B7E6-8C97C3858DEAQ35485478-94953A3C-E514-456C-A0B9-1249DDA23B5BQ36070925-81FED05B-5391-454F-ADD5-6A8FBE760534Q36149963-218E2DF6-9868-4EAC-894B-6BF2FFA48BBDQ36297809-17A381AD-A2E5-45B4-A950-1217CBE071EDQ36351543-7CF4BD1A-D2CB-416B-9C63-09E979E2E54BQ36390870-AD7AC833-A7D7-4A3B-B9ED-5A3BC8E0399DQ36443721-839BBB86-EA07-41AE-95F2-D911A44BBE22Q36459932-690476DA-8024-4230-A7F2-7FC7334A8DFCQ36580572-E3E2EAEA-3342-461D-9E40-BC7C205938F7Q36632760-76C6E3BC-5F5D-4EA8-9B20-226B64A67035Q36779849-98CEE74B-02AF-4474-965D-1863CF153125Q36790054-CA8FB30B-AE3A-49AD-A024-92D7701BFB20Q36842189-E4D6E692-E21A-4D7C-B5BE-18BF3090F0FDQ36847271-22FF0B46-3901-4EE9-9FDA-5F12F5FE844EQ36882599-AC2BBCD8-316E-4950-A76C-26F150DB50F2Q36972701-E397307D-F2B5-43DA-B9E5-D6A2F95D84D6Q37192717-810CEE53-C846-4039-9AC2-3066A45F70CEQ37356250-1FD53D61-3F3C-4B9F-AB18-6EC48F58FBF1Q37600783-53005EDB-5019-434F-8CB7-39F0F383DDFFQ37734694-447733C4-BB58-4384-8EE2-84E216CF541CQ37825377-44894D30-6EEE-4375-86E9-920703E25BD5Q37950422-AC04C3C3-B674-4ADE-9F47-14B2A8093FB8Q38064971-ECCC3AFC-C0EC-46CD-BE0E-BB42CA06056EQ38070888-EAF284FF-812F-407E-AECC-64D572CC8108Q38140018-98A836D2-1037-477B-85F7-F014DF3622EF
P2860
Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Randomized trial of modafinil ...... ents with Parkinson's disease.
@en
Randomized trial of modafinil ...... ents with Parkinson's disease.
@nl
type
label
Randomized trial of modafinil ...... ents with Parkinson's disease.
@en
Randomized trial of modafinil ...... ents with Parkinson's disease.
@nl
prefLabel
Randomized trial of modafinil ...... ents with Parkinson's disease.
@en
Randomized trial of modafinil ...... ents with Parkinson's disease.
@nl
P2093
P921
P356
P1433
P1476
Randomized trial of modafinil ...... ents with Parkinson's disease.
@en
P2093
John N Caviness
Joseph G Hentz
Judy Tiede
Marlene Lind
P304
P356
10.1002/MDS.10390
P407
P577
2003-03-01T00:00:00Z